Distortion product otoacoustic emissions as non-invasive biomarkers and predictors of soman-induced central neurotoxicity: A preliminary study

Toxicology

Volumn 238, Issue 2-3, 2007, Pages 119-129

  Job, Agnès ^a   Baille, Valérie ^a   Dorandeu, Frédéric ^a   Pouyatos, Benoît ^a   Foquin, Annie ^a   Delacour, Claire ^a   Denis, Josiane ^a   Carpentier, Pierre ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

Brain damage; Cholinesterases; Convulsions; Organophosphorus compounds; Otoacoustic emissions; Rat

Indexed keywords

BIOLOGICAL MARKER; CHOLINESTERASE; SOMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDIOMETRY; BLOOD; BRAIN DAMAGE; BRAIN FUNCTION; COCHLEA; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; INTOXICATION; MALE; NEUROTOXICITY; NONHUMAN; OTOACOUSTIC EMISSION; PRIORITY JOURNAL; RAT;

ACOUSTIC STIMULATION; ANIMALS; AUDIOMETRY; AUDIOMETRY, EVOKED RESPONSE; BRAIN; BRAIN CHEMISTRY; CHOLINESTERASE INHIBITORS; COCHLEA; INJECTIONS, SUBCUTANEOUS; MALE; NEUROTOXICITY SYNDROMES; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; SOMAN; SURVIVAL ANALYSIS; TIME FACTORS;

RATTUS;

EID: 34547781126     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.05.024     Document Type: Article

References (36)

1. Baille V., Dorandeu F., Carpentier P., Bizot J.C., Filliat P., Four E., Denis J., and Lallement G. Acute exposure to a low or mild dose of soman: Biochemical, behavioral and histopathological effects. Pharmacol. Biochem. Behav. 69 (2001) 561-569
2. Baille V., Clarke P.G.H., Brochier G., Dorandeu F., Verna J.M., Four E., Lallement G., and Carpentier P. Soman-induced convulsions: the neuropathology revisited. Toxicology 215 (2005) 1-24
3. Bhagat Y.A., Obenaus A., Hamilton M.C., and Kendall E.J. Magnetic resonance imaging predicts neuropathology from soman-mediated seizures in the rodent. Neuroreport 12 (2001) 1481-1487
4. Bhagat Y.A., Obenaus A., Hamilton M.G., Mikler J., and Kendall E.J. Neuroprotection from soman-induced seizures in the rodent: evaluation with diffusion- and T2-weighted magnetic resonance imaging. NeuroToxicology 26 (2005) 1001-1013
5. Carpentier P., Delamanche I.S., Le-Bert M., Blanchet G., and Bouchaud C. Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. NeuroToxicology 11 (1990) 493-508
6. Carpentier P., Foquin A., Rondouin G., LernerNatoli M., deGroot D.M.G., and Lallement G. Effects of atropine sulphate on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neuropathology. NeuroToxicology 21 (2000) 521-540
7. Carpentier P., Foquin A., Dorandeu F., and Lallement G. Delta activity as an early indicator for soman-induced brain damage: a review. NeuroToxicology 22 (2001) 299-315
8. Clark M.G., Sun W., Myers T.M., Bansal R., Doctor B.P., and Saxena A. Effects of physostigmine and human butyrylcholinesterase on acoustic startle reflex and prepulse inhibition in C57BL/6J mice. Pharmacol. Biochem. Behav. 81 (2005) 497-505
9. Crouzier D., Baille LeCrom V.B., Four E., Lallement G., and Testylier G. Disruption of mice sleep stages induced by low doses of organophosphorus compound soman. Toxicology 199 (2004) 59-71
10. Ellman G.L., Courney K.D., Andres V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
11. Elsmore T.F. Circadian susceptibility to soman poisoning. Fundam. Appl. Toxicol. 1 (1981) 238-241
12. Emmerich E., Richter F., Linss V., and Linss W. Frequency-specific cochlear damage in guinea pig after exposure to different types of realistic industrial noise. Hear. Res. 1-2 (2005) 90-98
13. Harris F.P. Distortion-product otoacoustic emissions in humans with high frequency sensorineural hearing loss. J. Speech Hear. Res. 33 (1990) 594-600
14. Hoskins B., Fernando J.C., Dulaney M.D., Lim D.K., Liu D.D., Watanabe H.K., and Ho I.K. Relationship between the neurotoxicities of soman, sarin and tabun, and acetylcholinesterase inhibition. Toxicol. Lett. 30 (1986) 121-129
15. Job A., and Nottet J.-B. DPOAEs in young normal-hearing subjects with histories of otitis media: evidence of sub-clinical impairments. Hear. Res. 167 (2002) 28-32
16. Job A., Cian C., Esquivié D., Leifflen D., Trousselard M., Charles C., and Nottet J.B. Moderate variation of mood/emotional states related to alterations in cochlear otoacoustic emissions and tinnitus onset in young normal hearing subjects exposed to gun impulse noise. Hear. Res. 193 (2004) 31-38
17. Jovic R.C. Correlation between signs of toxicity and some biochemical changes in rats poisoned by soman. Eur. J. Pharmacol. 25 (1974) 159-164
18. Kemp D.T., Ryan S., and Bray P. A guide to the effective use of otoacoustic emissions. Ear Hear. 11 (1990) 93-105
19. Khalfa S., Bougeard R., Morand N., Veuillet E., Isnard J., Guenot M., Ryvlin P., Fischer C., and Collet L. Evidence of peripheral auditory activity modulation by the auditory cortex in humans. Neuroscience 104 (2001) 347-358
20. Khvoles R., Freeman S., and Sohmer H. Transient evoked otoacoustic emissions can be recorded in the rat. Hear. Res. 97 (1996) 120-126
21. Lataye R., Campo P., Pouyatos B., Cossec B., Blachere V., and Morel G. Solvent ototoxicity in the rat and guinea pig. Neurotoxicol. Teratol. 25 (2003) 39-50
22. Lotti M. Cholinesterase inhibition: complexities in interpretation. Clin. Chem. 41 (1995) 1814-1818
23. McDonough J.H., and Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 21 (1997) 559-579
24. McDonough Jr. J.H., Jaax N.K., Crowley R.A., Mays M.Z., and Modrow H.E. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl. Toxicol. 13 (1989) 256-726
25. Mills C.D., Loos B.M., and Henley C.M. Increased susceptibility of male rats to kanamycin-induced cochleotoxicity. Hear. Res. 128 (1999) 75-79
26. Neill J.C., Liu Z., Mikati M., and Holmes G.L. Pilocarpine seizures cause age-dependent impairment in auditory location discrimination. J. Exp. Anal. Behav. 84 (2005) 357-370
27. Paludetti G., Di Nardo W., D'Ecclesia A., Evoli A., Scarano E., and Di Girolamo S. The role of cholinergic transmission in outer hair cell functioning evaluated by distortion product otoacoustic emissions in myasthenic patients. Acta Otolaryngol. 121 (2001) 119-121
28. Paul R.H., Cohen R.A., Gilchrist J.M., Aloia M.S., and Goldstein J.M. Cognitive dysfunction in individuals with myasthenia gravis. J. Neurol. Sci. 179 (2000) 59-64
29. Philippens I.H., Olivier B., and Melchers B.P. Effects of physostigmine on the startle in guinea pigs: two mechanisms involved. Pharmacol. Biochem. Behav. 58 (1997) 909-913
30. Pouyatos B., Gearhart C.A., and Fechter L.D. Acrylonitrile potentiates hearing loss and cochlear damage induced by moderate noise exposure in rats. Toxicol. Appl. Pharmacol. 204 (2005) 46-56
31. Puel J.-L., Ruel J., Guitton M., Wang J., and Pujol R. The inner hair cell synaptic complex: physiology, pharmacology and new therapeutic strategies. Audiol. Neurootol. 7 (2002) 49-54
32. Rasmussen A.N., Osterhammel P.A., Lund S.P., Kristiansen G.B., and Andersen S. A system for measuring distortion product otoacoustic emissions at ultra-sonic frequencies in rodents. Int. J. Audiol. 44 (2005) 237-243
33. Robinette M.S., and Glattke T.J. In: Glattke, and Thieme R. (Eds). Otoacoustic Emissions, Clinical Applications (2002), Stuttgart, New York 460
34. Sipos M.L., Burchnell V., and Galbicka G. Effects of selected anticholinergics on acoustic startle response in rats. J. Appl. Toxicol. 21 (2001) S95-S101
35. Testylier G., Lahrech H., Montignon O., Foquin A., Delacour C., Bernabe D., Segebarth C., Dorandeu F., and Carpentier P. Cerebral edema induced in mice by a convulsive dose of soman, evaluation through diffusion-weighted magnetic resonance imaging resonance and histology. Toxicol. Appl. Pharmacol. 220 (2007) 125-137
36. Tonduli L.S., Testylier G., Marino I.P., and Lallement G. Triggering of soman-induced seizures in rats: multiparametric analysis with special correlation between enzymatic, neurochemical and electrophysiological data. J. Neurosci. Res. 58 (1999) 464-473